Kathiawad Today

Seborrhoeic Dermatitis Market Size, Epidemiology, Treatment, Therapies and Companies by DelveInsight

 Breaking News
  • No posts were found

Seborrhoeic Dermatitis Market Size, Epidemiology, Treatment, Therapies and Companies by DelveInsight

June 17
01:05 2022
Seborrhoeic Dermatitis Market Size, Epidemiology, Treatment, Therapies and Companies by DelveInsight
Seborrhoeic Dermatitis Market

Seborrhoeic Dermatitis is a common chronic inflammatory skin condition, characterized by scaling and poorly defined erythematous patches. It may be associated with pruritus, and it primarily affects sebum-rich areas, such as the scalp, face, upper chest, and back, A milder variant is dandruff, which is manifested by dry, flaking scales on the scalp. The extent of involvement, as well as the severity of symptoms, helps to dictate treatment.


DelveInsight’s “Seborrhoeic Dermatitis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Seborrhoeic Dermatitis, historical and forecasted epidemiology as well as the Seborrhoeic Dermatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Some facts of the Seborrhoeic Dermatitis Market Report:

  • The market size of Seborrhoeic Dermatitis is anticipated to increase during the study period, 2019–2032.
  • As per Sessevile et al. (n.d) the prevalence of seborrheic dermatitis is increased among individuals with HIV infection, in whom it may be a presenting sign. The prevalence has been estimated to be around 35% among patients with early HIV infection and up to 85% among patients with acquired immunodeficiency syndrome (AIDS).
  • According to Clark et al. (2015), prevalence of seborrheic dermatitis is 1% to 3% in the general population and 34% to 83% in immune compromised persons. It has a bimodal distribution, with peaks at two to 12 months of age and in adolescence and early adulthood.
  • As per Berk & Scheinfeld, (2010) the prevalence of Seborrhoeic Dermatitis are limited by the absence of validated diagnostic criteria as well as a grading scale of severity; however, as one of the most common skin disorders, in the US, it affects approximately 11.6% of the general population and up to 70% of infants in the first three months of life may have the condition. Among adults, the peak incidence is in the third and fourth decades of life.
  • As per findings from secondary domain, males are most commonly affected in case of Seborrhoeic Dermatitis.
  • As per Berl et al. the worldwide prevalence of seborrheic dermatitis is around 5%, but the prevalence of its non-inflammatory variant, dandruff, is probably closer to 50%.
  • Current treatment for Seborrheic Dermatitis focuses on loosening scale, reducing inflammation and swelling, and curbing itch. The main goals of the prescribed therapies for Seborrheic Dermatitis are to clear the visible signs of the disease. As Seborrheic Dermatitis is associated with intermittent periods of relapse over several years, some preventative regimens have been identified. There is still a need of extensive research to understand the pathophysiology of this indication as well as the involvement of big pharmaceuticals key players to develop the better treatment modalities for this indication.


Get access to free sample report: https://www.delveinsight.com/sample-request/seborrhoeic-dermatitis-market


Scope of Seborrhoeic Dermatitis Market Report:

  • The report covers the descriptive overview of Seborrhoeic Dermatitis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Seborrhoeic Dermatitis epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Seborrhoeic Dermatitis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Seborrhoeic Dermatitis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Seborrhoeic Dermatitis market



Get access to free sample report: https://www.delveinsight.com/sample-request/seborrhoeic-dermatitis-market


Seborrhoeic Dermatitis Companies:

  • Arcutis Biotherapeutics
  • Cutanea Life Sciences
  • Moberg Pharma AB
  • Astion Pharma A/S
  • LEO Pharma
  • Bayer
  • Lexington International, LLC
  • Arcutis Biotherapeutics
  • Kamedis Ltd.
  • Amorepacific Corporation
  • And Many Others


Seborrhoeic Dermatitis Drugs:

  • ARQ 154
  • Omiganan
  • K40a
  • ASF1057
  • Azelaic Acid 15%
  • HairMax LaserComb
  • ARQ-154
  • And Many Others


Table of contents:

  1. Key Insights
  2. Executive Summary of Seborrhoeic Dermatitis
  3. Competitive Intelligence Analysis for Seborrhoeic Dermatitis
  4. Seborrhoeic Dermatitis: Market Overview at a Glance
  5. Seborrhoeic Dermatitis: Disease Background and Overview
  6. Patient Journey
  7. Seborrhoeic Dermatitis Epidemiology and Patient Population
  8. Treatment Algorithm, Current Treatment, and Medical Practices
  9. Unmet Needs
  10. Key Endpoints of Seborrhoeic Dermatitis Treatment
  11. Marketed Products
  12. Emerging Therapies
  13. Seborrhoeic Dermatitis: Seven Major Market Analysis
  14. Attribute analysis
  15. 7MM: Market Outlook
  16. Access and Reimbursement Overview of Seborrhoeic Dermatitis
  17. KOL Views
  18. Market Drivers
  19. Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer


Get access to free sample report: https://www.delveinsight.com/sample-request/seborrhoeic-dermatitis-market


About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-market